Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(5-arylamido-2-methylphenyl)-5-methylisooxazole-4-carboxamide deravative, pharmaceutical acceptable salt thereof, method for preparation therof and FMS kinase inhibitor comprising the same as anactive ingredient

N-(5-arylamido-2-methylphenyl)-5-methylisooxazole-4-carboxamide deravative, pharmaceutical acceptable salt thereof, method for preparation therof and FMS kinase inhibitor comprising the same as anactive ingredient

US Patent 9789086 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazole derivative expressing FLT3 inhibitory activity, and use thereof2025
2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmace2022
Benzimidazole derivative having JNK inhibitory activity and use thereof2020
Imidazole derivative having JNK inhibitory activity and use thereof2019
Thienodiazepine derivatives or pharmaceutically acceptable salts thereof, and ph2019
Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase2018
Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereo2017
2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors2016
1,6-disubstituted indole compounds as protein kinase inhibitors2014
Indazole derivatives or pharmaceutically acceptable salts thereof as protein kin2014
2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors2013
1,3,6-substituted indole derivatives having inhibitory activity for protein kina2012